Hypoparathyroid therapy
AssigneeAllergan, Inc.
InventorStephen Donovan
Life of this patent
Estimating the term…
Abstract
A method for treating hypoparathyroidism and/or hypocalcemia by local administration of a neurotoxin, such as a botulinum toxin, to a parathyroid gland, thereby reducing an inhibitory effect upon parathyroid hormone secretion. A method for treating hyperparathyroidism and/or hypercalcemia by local administration of a neurotoxin, such as a botulinum toxin, to a sympathetic ganglion which innervates a parathyroid hormone secreting parathyroid cell, thereby reducing a stimulatory effect upon parathyroid hormone secretion.
Claims4
A method for treating hypoparathyroidism, the method comprising the step of local administration in vivo to a parathyroid gland of a human patient of a therapeutically effective amount of a botulinum toxin_type A, B, C1, D, E, F or G, thereby increasing a deficient parathyroid hormone secretion from a parathyroid hormone secreting parathyroid cell and treating hypoparathyroidism.
A method for treating hypoparathyroidism, the method comprising the step of local administration in vivo to a parathyroid gland of a human patient of a therapeutically effective amount of a botulinum toxin type A, thereby increasing a deficient parathyroid hormone secretion from a parathyroid hormone secreting parathyroid cell and treating hypoparathyroidism.
Dependencies are inferred from the claim text.